1. Home
  2. ALHC vs ICUI Comparison

ALHC vs ICUI Comparison

Compare ALHC & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alignment Healthcare Inc.

ALHC

Alignment Healthcare Inc.

HOLD

Current Price

$21.43

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$131.06

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALHC
ICUI
Founded
2013
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.9B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
ALHC
ICUI
Price
$21.43
$131.06
Analyst Decision
Buy
Strong Buy
Analyst Count
8
4
Target Price
$23.13
$178.50
AVG Volume (30 Days)
3.0M
229.9K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
100.00
100.62
EPS
N/A
0.03
Revenue
$3,948,719,000.00
$2,231,262,000.00
Revenue This Year
$33.69
N/A
Revenue Next Year
$24.74
$4.46
P/E Ratio
$405.00
$4,330.17
Revenue Growth
46.06
N/A
52 Week Low
$11.63
$107.02
52 Week High
$23.87
$160.29

Technical Indicators

Market Signals
Indicator
ALHC
ICUI
Relative Strength Index (RSI) 64.20 53.24
Support Level $19.93 $130.63
Resistance Level $23.31 $133.62
Average True Range (ATR) 0.88 4.31
MACD 0.26 1.31
Stochastic Oscillator 79.35 99.24

Price Performance

Historical Comparison
ALHC
ICUI

About ALHC Alignment Healthcare Inc.

Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: